Cite
Piao L, Mukherjee S, Chang Q, et al. TriCurin, a novel formulation of curcumin, epicatechin gallate, and resveratrol, inhibits the tumorigenicity of human papillomavirus-positive head and neck squamous cell carcinoma. Oncotarget. 2016;8(36):60025-60035doi: 10.18632/oncotarget.10620.
Piao, L., Mukherjee, S., Chang, Q., Xie, X., Li, H., Castellanos, M. R., Banerjee, P., Iqbal, H., Ivancic, R., Wang, X., Teknos, T. N., & Pan, Q. (2017). TriCurin, a novel formulation of curcumin, epicatechin gallate, and resveratrol, inhibits the tumorigenicity of human papillomavirus-positive head and neck squamous cell carcinoma. Oncotarget, 8(36), 60025-60035. https://doi.org/10.18632/oncotarget.10620
Piao, Longzhu, et al. "TriCurin, a novel formulation of curcumin, epicatechin gallate, and resveratrol, inhibits the tumorigenicity of human papillomavirus-positive head and neck squamous cell carcinoma." Oncotarget vol. 8,36 (2017): 60025-60035. doi: https://doi.org/10.18632/oncotarget.10620
Piao L, Mukherjee S, Chang Q, Xie X, Li H, Castellanos MR, Banerjee P, Iqbal H, Ivancic R, Wang X, Teknos TN, Pan Q. TriCurin, a novel formulation of curcumin, epicatechin gallate, and resveratrol, inhibits the tumorigenicity of human papillomavirus-positive head and neck squamous cell carcinoma. Oncotarget. 2016 Jul 16;8(36):60025-60035. doi: 10.18632/oncotarget.10620. eCollection 2017 Sep 01. PMID: 28947951; PMCID: PMC5601119.
Copy
Download .nbib